| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 02/23/2005 | CN1585754A Quinazoline derivatives as antitumor agents |
| 02/23/2005 | CN1585746A Beta-amyloid protein production/secretion inhibitors |
| 02/23/2005 | CN1585742A Aryl aniline beta-2 adrenergic receptor agonists |
| 02/23/2005 | CN1585636A Use of endothelin receptor antagonists in the treatment of tumour diseases |
| 02/23/2005 | CN1585633A Phenethanolamine derivatives for treatment of respiratory diseases |
| 02/23/2005 | CN1583729A Method for synthetizing orixine and RU-19110 intermediate |
| 02/23/2005 | CN1583728A Compound extracted from eucalyptus plant and use thereof |
| 02/23/2005 | CN1190434C Novel heterocyclic compounds and process for its preparation, and pharmaceutical compositions containing them and their use in treatment of diabetes and related diseases |
| 02/23/2005 | CN1190427C Method for preparing pyrimidine derivative |
| 02/23/2005 | CN1190424C Quinoline-containing Alpha-ketoamide cysteine and serine protease inhibitors |
| 02/22/2005 | US6858618 Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia |
| 02/22/2005 | US6858611 Antiarrhythmia agents; cardiovascular disorders |
| 02/22/2005 | US6858610 Autoimmune disease; antiinflammatory agents |
| 02/22/2005 | US6858606 Nitrogen compounds such as 1-(2-(4-(N'-(3-Methyl-benzylidene)-hydrazino)-6-morpholin-4-yl-pyrimidin-2 -yloxy)-ethyl)-1H-pyridin-2-one, used to control interleukin production; antiinflammatory agents |
| 02/22/2005 | US6858396 Amino acids where primary amine group is replaced by azide; use in peptides screening for bioactivity, crossing blood-brain barrier, increasing selectivity; treating brain disorders |
| 02/22/2005 | CA2129039C Tri-substituted phenyl derivatives as phosphodiesterase inhibitors |
| 02/17/2005 | WO2005014573A1 Anthelmintic and insecticide pyrimidine derivatives |
| 02/17/2005 | WO2005014563A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 02/17/2005 | WO2005014558A1 Condensed pyramidine compounds as inhibitors of voltage-gated ion channels |
| 02/17/2005 | WO2005014557A1 Tetrahydroquinazoline derivatives as cfr antagonists |
| 02/17/2005 | WO2005014556A1 2-aminopyrimidine derivatives |
| 02/17/2005 | WO2005013997A1 Spiro-substituted tetrahydroquinazolines as corticotropin releasing factor (cfr) antagonists |
| 02/17/2005 | WO2005013914A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 02/17/2005 | WO2005013903A2 Derivatives of substituted quinone and uses thereof |
| 02/17/2005 | US20050038243 2, 4-pyrimidinediamine compounds and their uses |
| 02/17/2005 | US20050038082 Fungicides such as 2-hydroxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-3-phenyl-propionamide; etherification, amidation, sulurization |
| 02/17/2005 | US20050038057 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; utility in treatment of a variety of sex-hormone related conditions in both men and women |
| 02/17/2005 | US20050038056 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 02/17/2005 | US20050038055 Spiro tetrahydroquinazolines and dihydrocyclopentapyrimidines as CRF antagonists |
| 02/17/2005 | US20050038052 Tetrahydroquinazolines and dihydrocyclopentapyrimidines as CRF antagonists |
| 02/17/2005 | US20050038051 Novel molecules for regulating cell death |
| 02/17/2005 | US20050038050 Therapeutic treatment of autoimmune disease, transplant rejection, rheumatoid arthritis, by administering 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline |
| 02/17/2005 | US20050038041 Fungicide for agriculture, horticulture |
| 02/17/2005 | US20050038035 Heterocyclic amide compounds as apolipoprotein b inhibitors |
| 02/17/2005 | US20050038016 Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists |
| 02/17/2005 | US20050038002 Bactericides; antitumor agents; moderators of gene expression; viricides; parasiticides; malaria therapy |
| 02/17/2005 | CA2554566A1 Condensed pyramidine compounds as inhibitors of voltage-gated ion channels |
| 02/17/2005 | CA2539227A1 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 02/17/2005 | CA2535249A1 Spiro-substituted tetrahydroquinazolines as corticotropin releasing factor (cfr) antagonists |
| 02/17/2005 | CA2534975A1 Anthelmintic and insecticide pyrimidine derivatives |
| 02/17/2005 | CA2534785A1 Tetrahydroquinazoline derivatives as cfr antagonists |
| 02/17/2005 | CA2534675A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 02/17/2005 | CA2534292A1 Substituted imidazopyrimidines for the prevention and treatment of cancer |
| 02/17/2005 | CA2532431A1 "7-substituted 3-nitro-pyrazolo [1,5-a] pyrimidines" |
| 02/16/2005 | EP1506967A1 Dipeptidyl peptidase inhibitors |
| 02/16/2005 | EP1506962A2 Nitrogen-containing aromatic heterocycles |
| 02/16/2005 | EP1506169A1 Method for the production of sulphamic acid halogenides |
| 02/16/2005 | EP1506166A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| 02/16/2005 | EP1505980A1 Microbicidal pyrimidine or triazine for preventing sexual hiv transmission |
| 02/16/2005 | EP0986540B1 The use of carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones as sodium channel blockers |
| 02/16/2005 | CN1582285A Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (GSK3 inhibitors) |
| 02/16/2005 | CN1582281A Mch受体拮抗剂 Mch receptor antagonist |
| 02/16/2005 | CN1582277A Amide derivatives as glycogen synthase kinase 3-beta inhibitors |
| 02/15/2005 | US6855843 Antihistamines; rheumatic diseases; antidiabetic agents; inflammatory bowel disorders |
| 02/15/2005 | US6855716 Dihydropyrimidine compounds and compositions containing the same |
| 02/15/2005 | US6855706 Phenylalanine derivatives |
| 02/15/2005 | CA2153242C 2-alkoxy-4-hydrazinopyrimidine compounds and their use in the preparation of 5-alkoxy-1,2-4-triazolo[4,3-c]pyrimidine-3(2h)-thione compounds |
| 02/10/2005 | WO2005012264A1 Process for producing 6,7-bis(2-methoxyethoxy)-quinazolin-4-one |
| 02/10/2005 | WO2005012263A1 5-ht2b receptor antagonists |
| 02/10/2005 | WO2005012262A1 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors |
| 02/10/2005 | WO2005012261A1 2-substituted pyrimidines |
| 02/10/2005 | WO2005012241A2 p-38 KINASE INHIBITORS |
| 02/10/2005 | WO2005012228A1 O-coordinated metal chelates and their use in optical recording media having high storage capacity |
| 02/10/2005 | WO2005012220A2 Cycloalkylidene compounds as modulators of estrogen receptor |
| 02/10/2005 | WO2005011657A2 Piperazine derivatives and their use as therapeutic agents |
| 02/10/2005 | WO2004060305A3 Anti-cancer medicaments |
| 02/10/2005 | US20050033047 such as 2-dimethylaminocarbonyl-5-nitro-n-4-[(4,6-dimethoxypyrimidin-2-yl)aminocarbonyl]benzene-sulfonamide via halogenation, ammonolysis, reduction, and reaction with carbamates; herbicides; plant growth regulators |
| 02/10/2005 | US20050032864 Azolidinedione derivatives such as 5-[4-[[3-methyl-4-oxo-3,4-dihydro-2-quinazolinyl]methoxy]phenylmethyl]thiazolidine-2,4-dione potassium salt; dyslipidaemia; eating, cardiovascular and kidney disorders; atherosclerosis, obesity, psoriasis, polycystic ovarian syndrome; hypotensive agents |
| 02/10/2005 | US20050032823 analgesics; antipyretics; antiinflammatory agents; antiarthritic agents |
| 02/10/2005 | US20050032822 E.g., 5-dinitro-2-dimethyldithio-carbamoyl-pyridine; strong bacteriacidal activity, especially against mycobacteria; tuberculosis and leprosy caused by mycobacteria and infectious diseases caused by staphylococci; side effect reductions; effective against drug, multidrug-resistant infections |
| 02/10/2005 | US20050032821 2-etherified 4-fluoroalkyl-6-(p-sulfonylphenyl)pyrimidines,e.g., 2-(4-fluorophenoxy)-4-[4-(methylsulfonyl)phenyl]-6](trifluoromethyl)pyrimidine; treatment of the pain, fever and inflammation of variety of conditions and diseases |
| 02/10/2005 | US20050032810 Novel anthelmintic and insecticidal compositions |
| 02/10/2005 | US20050032809 5-HT receptor ligands and uses thereof |
| 02/10/2005 | US20050032805 Antimicrobial biaryl compounds |
| 02/10/2005 | US20050032797 Fluorinated di-aryl urea compounds |
| 02/10/2005 | US20050032794 For example, 2-Dimethylamino-N-(3-dimethylamino-1,4-dioxo-1,4-dihydro-naphthalen-2-yl)-N-methyl-acetamide; ability to function as gene expression modulators for genes found in cancer cells, especially genes involved in misregulated signal transduction pathways typical of cancers of colon and breast |
| 02/10/2005 | US20050032738 (E)-2'-deoxy-2'-fluoromethylidenecytidine, cytidine, vinblastine, or fluorouracil; leukemia |
| 02/10/2005 | CA2534990A1 P-38 kinase inhibitors |
| 02/10/2005 | CA2533901A1 Piperazine derivatives and their use as therapeutic agents |
| 02/10/2005 | CA2533474A1 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors |
| 02/10/2005 | CA2532718A1 2-substituted pyrimidines |
| 02/10/2005 | CA2532505A1 5-ht2b receptor antagonists |
| 02/09/2005 | EP1505064A1 2-Aminopyrimidine derivatives |
| 02/09/2005 | EP1504759A1 Oral therapeutic or preventive drugs for pollakiuria and urinary incontinence or oral sleep inducers, containing tropolone derivatives |
| 02/09/2005 | EP1503994A1 Substituted (thioxo)carbonylamino phenyl uraciles |
| 02/09/2005 | EP1503993A2 Compounds, methods and compositions |
| 02/09/2005 | EP1503981A2 Substituted tetracycline compounds |
| 02/09/2005 | EP1503763A1 Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith |
| 02/09/2005 | EP1100789B1 Substituted benzoylcyclohexandiones |
| 02/09/2005 | CN1578779A Small organic molecule regulators of cell proliferation |
| 02/09/2005 | CN1578767A Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
| 02/09/2005 | CN1578659A Modulators of peroxisome proliferator activated receptors (ppar) |
| 02/09/2005 | CN1576275A Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 02/09/2005 | CN1576274A Substituted aryl sulphonyl(thio)ureas used as herbicides |
| 02/09/2005 | CN1575816A Compounds for the treatment of female sexual dysfunction |
| 02/09/2005 | CN1188401C Heterocyclic amide compound and its pharmaceutical use |
| 02/09/2005 | CN1188400C Optically active ureido-pyrimidine compounds |
| 02/09/2005 | CN1188397C Process for preparation of acid chloride compounds |
| 02/08/2005 | US6852717 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor; for use in therapy of diseases and pathological conditions involving inflammation such as chronic inflammatory disease |